GNBTQ Generex Biotechnology Corp.

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Harrison Ford Honored with the E.O. Wilson Legacy Award Recently, a momentous event occurred as the E.O. Wilson Biodiversity Foundation recognized the unparalleled contributions of actor and environmental advocate Harrison Ford with the prestigious E.O. Wilson Legacy Award for Transformative Conservation Leadership. This event took place during the Half-Earth Day...

Interpace Biosciences Aims for Nasdaq Uplisting Interpace Biosciences, Inc. (OTCQX: IDXG) has recently announced a proactive move to strengthen its position in the stock market. The company is restructuring its preferred stock as a strategic first step toward seeking an uplisting of its common stock to Nasdaq. This initiative is facilitated through an agreement with its...

HITN and Curiosity Team Up for Exciting Content HITN, the premier Spanish-language public media network in the United States, has formed a strategic alliance with Curiosity, a global media powerhouse known for its award-winning documentaries and factual content. This collaboration is an essential move to deliver an extensive array of engaging and educational programming...

Metallium’s Groundbreaking Achievement in Rare Earth Elements Metallium Ltd. (OTCQX: MTMCF) has taken a remarkable leap in advancing rare-earth refining technology. With the establishment of exclusive rights to treat ore from the Harts Range Project, the company is set to lead a critical supply chain for heavy rare earth elements. Exceptional Results from Flash Joule...

The Current State of German Business Confidence Germany's corporate landscape is facing a rocky start as the new year unfolds, with sentiment levels showing little improvement. The Ifo Institute's recent business-climate index registered at 87.6 in January, disappointing analysts who had anticipated a slight rise to 88.0. This stagnation is indicative of the persistent...